ALKBH5 and gastric cancer: In contrast, high expression of ALKBH5 (HR = 0.94, 95% CI = 0.89–0.98) and RBM15 (HR = 0.83, 95% CI = 0.74–0.93), have a better survival in patients with gastric cancer (Figure 4A).